ARCHIVES

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

This article is from The Cancer Letter archive.

Vol. 21 No. 30 | July 28, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Lists Therapies being Tested For AIDS, Opportunistic Infections

January 24, 1992

NRC Reports Says NIH Security Of nuclear Materials a Problem

January 5, 1996

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

August 4, 1995

Barbara Rimer and Owen Witte To Be Named Members Of the President’s Cancer Panel

December 9, 2011

ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies

May 2, 2003

Anti-Estrogen Drug Therapy Reduces Risk of Invasive Breast Cancer In Older Women

July 25, 2008